NCT03448887View on ClinicalTrials.gov

Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

July 15, 2020

Study Completion Date

August 31, 2020

Conditions
Kidney Failure, ChronicRenal Dialysis
Interventions
DEVICE

Theranova

Extended HD with theranova

DEVICE

Online hemodiafiltration

Online hemodiafiltration

Trial Locations (4)

13620

Seoul National University Bundang Hospital, Gyeonggi-do

03080

Seoul National University Hospital, Seoul

06351

Samsung Medical Center, Seoul

06591

Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT03448887 - Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration | Biotech Hunter | Biotech Hunter